Deutsche Bank
LGND icon

Deutsche Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Deutsche Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-802
Closed -$57K – 5107
2019
Q2 		$57K Sell
802
-99
-11% -$7.29K ﹤0.01% 4464
2019
Q1 		$70K Sell
901
-1,513
-63% -$115K ﹤0.01% 4445
2018
Q4 		$204K Buy
+2,414
New +$257K ﹤0.01% 3864

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's LGND Position: Q2 2026 in Review

Deutsche Bank reduced its Ligand Pharmaceuticals (LGND) stake by 18% in Q2 2026, selling an estimated $13.3M and leaving 249,611 shares worth $78.9M. The position accounts for 0.02% of the portfolio, ranked #558.

Deutsche Bank first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. The position peaked at $115M in Q2 2018. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Deutsche Bank held 249,611 shares of Ligand Pharmaceuticals worth $78.9M as of Q2 2026.
  • Deutsche Bank sold 56,500 Ligand Pharmaceuticals shares in Q2 2026, an estimated $13.3M.
  • Ligand Pharmaceuticals made up 0.02% of Deutsche Bank's portfolio in Q2 2026, its #558 holding.
  • Deutsche Bank first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Ligand Pharmaceuticals position peaked at $115M in Q2 2018.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.